Stock data
Bluejay Diagnostics, Inc. (BJDX)
Bluejay Diagnostics, Inc. (BJDX) reported net income of -US$6.85M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$6.95M | -US$6.85M | — |
| 2024 | — | — | -US$7.17M | -US$7.72M | — |
| 2023 | — | — | -US$10.31M | -US$9.95M | — |
| 2022 | US$0.25M | US$0.05M | -US$9.32M | -US$9.30M | — |
| 2021 | — | — | -US$3.23M | -US$3.49M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$2.32M | — |
| 2026-03-31 | — | -US$1.92M | — |
| 2025-12-31 | — | -US$1.43M | — |
| 2025-09-30 | — | -US$1.60M | — |
| 2025-06-30 | — | -US$1.96M | — |
| 2025-03-31 | — | -US$1.86M | — |
| 2024-12-31 | — | -US$1.43M | — |
| 2024-09-30 | — | -US$1.48M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.